Insmed
INSM
#1145
Rank
NZ$36.12 B
Marketcap
NZ$166.65
Share price
-2.69%
Change (1 day)
0.55%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -NZ$2.05 Billion

According to Insmed's latest financial reports the company's current earnings are NZ$0.60 Billion. a decrease over its 2024 earnings that were of -NZ$1.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$2.08 Billion43.91%
2024 -NZ$1.45 Billion23.71%
2023 -NZ$1.17 Billion45.77%
2022 -NZ$0.81 Billion15.83%
2021 -NZ$0.7 Billion50.19%
2020 -NZ$0.47 Billion16.4%
2019 -NZ$0.4 Billion-23.9%
2018 -NZ$0.52 Billion59.35%
2017 -NZ$0.33 Billion8.52%
2016 -NZ$0.31 Billion47.25%
2015 -NZ$0.21 Billion34.53%
2014 -NZ$0.16 Billion58.83%
2013 -NZ$95.48 Million35.14%
2012 -NZ$70.65 Million-31.92%
2011 -NZ$0.11 Billion854.92%
2010 -NZ$10.87 Million-105.22%
2009 NZ$0.20 B-905.06%
2008 -NZ$25.85 Million-27.31%
2007 -NZ$35.56 Million-62.41%
2006 -NZ$94.59 Million98.19%
2005 -NZ$47.73 Million0.03%
2004 -NZ$47.71 Million159.07%
2003 -NZ$18.42 Million-69.31%
2002 -NZ$60.01 Million
2000 -NZ$54.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.45 B-1,421.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
NZ$17.04 B-920.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.80 B-523.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-NZ$1.23 Billion-41.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-NZ$40.44 Million-98.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-NZ$3.29 Million-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA